Abstract
INTRODUCTION
Gastric cancer is one of the most common malignancies, being the fourth most common cancer and the second leading cause of cancer related deaths (740 000 deaths in 2008), with nearly one million newly diagnosed cases each year [1] . Up to now, the exact molecular mechanisms involved in carcinogenesis and progression of gastric cancer have remained unclear. Therefore, investigating the cell proliferation and apoptosis involved in these processes is essential for gastric cancer research.
The high mobility group A2 (HMGA2) gene is a member of the high mobility group AT-hook (HMGA) gene family. HMGA2 plays a critical role in several cellular biological processes, including cell transformation, growth, differentiation, senescence and cycle control [2] [3] [4] . Normally, HMGA2 is abundantly expressed during embryogenesis, whereas its expression is low or absent in normal adult differentiated tissues [5, 6] . Evidence shows that HMGA2 is overexpressed in breast cancer [7] , pancreatic cancer [8, 9] , esophageal squamous cell carcinoma [10] , non-small cell lung cancer [11] , oral squamous cell cancer [12] , bladder cancer [13] , ovarian cancer [14, 15] and colorectal cancer [16, 17] . Its expression is correlated with malignant degree, pathological type and metastasis [18] . Thus, HMGA2 might play a central role in the disease progression of many types of tumors. Overexpression of HMGA2 has also been described in gastric cancer [19] . The study showed that the overexpression of HMGA2 in gastric cancer patients was significantly correlated with poor prognosis and low overall survival. However, the exact mechanism of HMGA2 in gastric cancer is not clear.
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway plays a central role in many human cancers. Akt regulates cell proliferation, differentiation and apoptosis via activation or inhibition of downstream target proteins, such as P27, caspase-9 and B-cell leukemia/lymphoma-2 (Bcl-2) [20, 21] . The aims of the present study were to investigate the effect of HMGA2 expression on gastric cancer cell proliferation and apoptosis. Moreover, the expressions of PI3K, Akt, P27, caspase-9 and Bcl-2 were detected to exploit the possible mechanism.
MATERIALS AND METHODS

Construction of HMGA2-shRNA expression plasmid
The human HMGA2 was treated as the target gene (Accession Number: NM-003484) and four pairs of short hairpin RNA (shRNA) oligonucleotides were designed and synthesized (Cyagen Biosciences Inc., United States). A pair of random scrambled sequences, which have no homologous relation with any human gene sequences and whose shRNAs would not interfere with human mRNA were also designed ( Table 1 ). The complementary form was obtained by annealing, which was then cloned and inserted into vector pLLU2 to construct a recombinant plasmid. The plasmid was transformed into stb13 strain. Finally, the plasmid was identified by restriction enzyme digestion and sequenced (Cyagen Biosciences Inc., United States). According to the preliminary experimental results, the first pair shRNA oligonucleotides (Table 1) was the best interfering sequence, and the recombinant plasmid harboring it was used for subsequent experiments.
Cell culture and transfection
Gastric cancer MKN-45 cells (ATCC, United States) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Solarbio Science and Technology Co., Ltd., Beijing, China) containing 10% placental bovine serum. After 24 h incubation at 37 ℃ with 5% CO2, logarithmic growth phase cells in good condition were digest by 0.25% trypsin + ethylenediaminetetraacetic acid. After calculating the cell number, cells were seeded into 6-well plates at 1 × 10 5 cells per well. When the cells reached more than 80% confluence (usually the next day), plasmid and lipofectamine were added dropwise to form a mixture of 1:1 with mixing. After culturing in serum-free and antibioticfree DMEM for 6 h, the culture medium was replaced by DMEM and the cultured was continued for 24 h. The cells were then transfected using a Lipofectamine 
Reverse transcription polymerase chain reaction analysis
Total RNA was isolated using TRIzol (Sangon Biotech Co., Ltd., Shanghai, China). A Reverse Transcriptase Kit (Fermentas China Co., Ltd.) was used to create cDNA, according to the manufacturer's instructions: 1 μg RNA, Oligo dT18 as the primer, and 42 ℃ for 60 min followed by 70 ℃ for 5 min. Reverse transcriptase polymerase chain reaction (RT-PCR) assays were carried out using on an ABI 2720 (Applied Biosystems, Foster City, CA, United States). The PCR primers (synthesized by Sangon Biotech Co., Ltd., Shanghai, China) used to detect HMGA2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were as follows: HMGA2, upstream primer 5'-TACTCTGTCTCTGCCTGTGC-3', downstream primer 5'-GGAGTGAATTGTGTCCCTTGA-3' (product length 228 bp); GAPDH, upstream primer 5'-GAAGGTGAAGGTCGGAGTC-3', downstream primer 5'-TCACACCCATGACGAACAT -3' (product length 401 bp). The 25 μL PCR amplification reaction mixture contained: cDNA, 1.5 μL; Taq Mix, 12.5 μL; 10 μmoL/L; each primer, 1 μL; RNase-free Water, 9 μL. Amplification reaction program: initial denaturation at 95 ℃ for 5 min; 35 cycles of denaturation at 94 ℃ for 30 s, annealing at 58 ℃ for 35 s, extension at 72 ℃ for 30 s; and final extension at 72 ℃ for 7 min. The PCR products were analyzed on agarose gels; gel analysis software was used to analyze the bands. The gray value ratio of the objective band and the β-actin band indicated the relative expression levels of HMGA2 mRNA.
Western blotting analysis of the protein expression levels of HMGA2, PI3K, Akt, P27, caspase-9 and Bcl-2 Cells were lysed in RIPA cell lysis buffer (Sangon Biotech Co., Ltd., Shanghai, China). The ratio of lysate and loading buffer was 4:1, degeneration and proteins were extracted. About 80 μg of proteins were fractionated by electrophoresis on sodium dodecyl sulfate-polyacrylamide gels and electroblotted onto a polyvinylidene fluoride membrane. The membrane was blocked with 5% nonfat milk for 2 h at room temperature and incubated overnight with the primary antibody (Santa Cruz Biotechnology, inc., United States). The membrane was washed with Tris-Buffered-Saline with Tween (TBST) three times for 10 min each, and then incubated for 2 h at room temperature with the secondary antibody (Zhongshanjinqiao Biotechnology Co., Ltd., Beijing, China). The membranes were washed with TBST 3 times for 10 min each, before being developed and fixed. β-actin (Zhongshanjinqiao Biotechnology Co., Ltd., Beijing, China) was used as an internal control. Gel analysis software was used to scan and analyze the bands. The gray value ratio of objective band and internal loading control band was used to determine the objective proteins expression levels.
Flow cytometric analysis of cell apoptosis
Each group of cells was digested into a single cell suspension using 0.25% trypsin. One hundred μL of buffer from the Annexin v-FITC and PE Apoptosis Detection Kit (BD Co., United States), 5 μL ADD and 5 μL PE were added to the cells, which were incubated without shaking at room temperature for 15 min in the dark. About 400 μL of buffer was then added, then the apoptosis rate of each group of cells was assayed by flow cytometry.
In vitro cell proliferation assay
A suspension of each group of cells was obtained by 0.25% trypsin digestion. The cells were centrifuged (1000 g, 5 min), resuspended in 1 mL culture medium and counted. A cell suspension containing 2 × 10 4 /200 μL cells was distributed into 96-well plates: six sets of parallel holes were used for each group. The cells were then incubated at 37 ℃ in 5% CO2. One 96-well plate was removed daily and 20 μL per well of a fresh new methyl thiazol tetrazolium (MTT) solution (5 mg/mL) was added, and the plate incubated at 37 ℃ for 4 h. The supernatants were removed, and 150 μL of dimethyl sulfoxide was added to each well and the plates were oscillated for 10 min. The optical density value (A value) of the cells in each well was measured by an enzyme-labeling instrument at a wavelength of 570 nm, and a growth curve for the cells was drawn. The cell proliferation inhibition rate (CPIR) was calculated according to the formula: CPIR (%) = (1 -A experimental group /A control group) × 100%.
Statistical analysis SPSS 13.0 software (Chicago, United States) was used to perform the statistical analysis. Data were expressed as mean ± SD. One-way analysis of variance was used to analyze the correlation of data among three or more groups, and an SNK test was used for pairwise comparison between groups. P < 0.05 was considered significant.
RESULTS
Fluorescence microscopy analysis of cell transfection
The result showed that the transfection efficiency of the significantly decreased, the difference was statistically significant (0.113 ± 0.032 vs 0.554 ± 0.082 and 0.484 ± 0.123, P < 0.05); however, the difference between the blank control group and the scrambled sequence group was not statistically significant (P > 0.05) (Figure 2) . The results showed that transfection of HMGA2 shRNA expression vector had significantly inhibited the protein expression from the target gene.
Apoptosis analysis of gastric cancer cells
The cell apoptotic rate of the transfected group was significantly higher than that of the blank control group and scrambled sequence group; the difference was statistically significant (P < 0.05). The highest cell apoptotic rate appeared at 48 h after transfection. The difference between the blank control group and the scrambled sequence group was not statistically significant (P > 0.05) (Figure 3 ).
Cell proliferation assay
The MTT assay revealed that there were remarkable diftransfected group cells was 60%-70% after transfection for 48 h and was significantly higher than that at 24 h. Compared with 48 h, there was no significant change at 72 h. The scrambled sequence group cells were not transfected at any time ( Figure 1 ).
Expression of HMGA2 mRNA in each group of cells
Compared with the blank control group and the scrambled sequence group, the expression of HMGA2 mRNA in the transfected group was significantly reduced (0.374 ± 0.048 vs 0.674 ± 0.129 and 0.689 ± 0.124, P < 0.05); however, the difference between the blank control group and the scrambled sequence group was not statistically significant (P > 0.05) (Figure 2) . The results showed that the RNA interference had a targeted inhibition affect on the HMGA2 gene.
Expression of HMGA2 protein in each group of cells
Compared with the blank control group and scrambled sequence group, the HMGA2 the protein expression was ferences in cell proliferation at 24, 48 and 72 h after transfection with shRNA. The most obvious cell proliferation inhibition appeared at 48 h after transfection in the transfected group (P < 0.05). There was no significant difference in the inhibition rate of the blank control group and the scrambled sequence group (P > 0.05) (Figure 3) .
Expression of PI3K, Akt, P27, caspase-9 and Bcl-2 proteins
Compared with the blank control group and scrambled sequence group, after transfection of shRNA for 72 h, the protein expression levels of PI3K (0.042 ± 0.005 vs 0.069 ± 0.003 and 0.067 ± 0.05, P < 0.05), Akt (0.248 ± 0.004 vs 0.489 ± 0.006 and 0.496 ± 0.104, P < 0.05) and Bcl-2 (0.295 ± 0.084 vs 0.592 ± 0.072 and 0.594 ± 0.109, P < 0.05) were significantly reduced. Difference between the blank control group and the scrambled sequence group were statistically significant (P > 0.05) ( Figure 4A and B) . The protein expression levels of P27 (0.151 ± 0.010 vs 0.068 ± 0.014 and 0.060 ± 0.013, P < 0.05) and caspase-9 (0.136 ± 0.042 vs 0.075 ± 0.010 and 0.073 ± 0.072, P < 0.05) were significantly upregulated.
The difference between the blank control group and the scrambled sequence group was not statistically significant (P > 0.05) ( Figure 4C and D) .
DISCUSSION
Activation of oncogenes, inactivation of suppressor genes and abnormal expression of apoptosis-related genes are closely related to carcinogenesis and progression of gastric cancer. HMGA2 is a transcription factor that is involved in transcriptional regulation of various tumor-related genes [22] . Several studies [14, 15, 23] have showed that HMGA2 plays a critical role in the processes of many tumors, including enhancing cell growth and invasion. Moreover, the prognosis of patients with high HMGA2 expression is worse than those with low HMGA2 expression [24, 25] . The clinical association of HMGA2 with gastric cancer has been reported [19] . The study showed that overexpression of HMGA2 appeared in human gastric cancer, and might be involved in cancer invasion and metastasis. However, the exact mechanism of HMGA2's involvement in gastric cancer is not clear, especially in relation to signaling pathways and the molecular mechanism.
In the present study, fluorescence microscopy revealed that the transfection efficiency of the transfected group cells can reach about 60%-70%, and that recombinant plasmid was effectively expressed in cells. HMGA2 shRNA transfection could effectively inhibit the expression of HMGA2 gene. The inhibition was achieved without off-target effects, which was confirmed at the mRNA and protein levels by RT-PCR and Western blotting. According to the results of MTT and flow cytometry, cell proliferation was inhibited and apoptosis was increased after transfection. Therefore, we conclude that HMGA2 shRNA gene silencing can effectively induce proliferation inhibition and apoptosis of MKN-45 cells in vitro without off-target effects.
The PI3K/Akt signaling pathway plays important roles in cell survival and resistance to apoptosis [26] ; it has been shown to be activated in many cancers and activated Akt acts to phosphorylate P27, caspase-9 and Bcl-2 to promote the resistance of cancer cells to apoptosis [20, 21] . A study showed that activation of the PI3K/Akt signaling pathway is induced by overexpression of HMGA2 [27] . In this study, western blotting showed that the expressions of PI3K and Akt protein were reduced in the transfected group. Thus, decreased expression of HMGA2 inhibits the activity of thePI3K/Akt signaling pathway.
P27 is a cyclin-dependent kinase (CDK) inhibitor that functions as a fail-safe mechanism in DNA repair and apoptosis [28] . A report showed that the P27 gene reduced cell mitosis division and inhibited cell generation [29] . Overexpression of P27 inhibits CDK activation and entry into the S phase of the cell cycle [30] . The expression level of P27 was positively correlated with cell differentiation, and its loss of function may subsequently contribute to tumorigenesis [31] . Caspase-9, a member of the protease family, is intimately associated with the initiation of apoptosis, and is thought to be activated, while Akt is inhibited [32] . Activated caspase-9 is able to cleave caspase-3, leading to apoptosis [33] . Bcl-2 is a key anti-apoptotic protein involved in the regulation of apoptosis and is overexpressed in many tumors [34] [35] [36] . A previous study showed that Bcl-2 delays cell cycle entry by inhibiting Myc activity through the elevation of p27. Bcl-2 can be induced to express via the PI3K/Akt signaling pathway and inhibit cell apoptosis [21, 37] . In our study, western blotting revealed that the protein expression levels of Bcl-2 were reduced, whereas the protein expression level of P27 and caspase-9 were upregulated. Thus, decreased expression of HMGA2 inhibits the activity of the PI3K/Akt signaling pathway, and than inhibits cells proliferation and increases apoptosis via upregulation of the protein expression of P27 and caspase-9, and decreased protein expression of Bcl-2.
In summary, our results demonstrated that HMGA2 shRNA gene silencing could induce apoptosis and suppress proliferation of MKN-45 cells in vitro. The PI3K/ Akt signaling pathway, P27, caspase-9 and Bcl-2 may play important roles in this HMGA2-mediated effect. We suggest that HMGA2 shRNA gene silencing may be suitable for gastric cancer therapy by suppressing the proliferation and inducing apoptosis of gastric cancer cells.
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